Cargando…
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
BACKGROUND: Patients with exudative age-related macular degeneration (AMD) who did not respond to ranibizumab at the induction phase were assessed and referred to as initial non-responders. METHODS: We retrospectively reviewed the medical records of 215 patients (218 eyes) with exudative AMD. For th...
Autores principales: | Otsuji, Tsuyoshi, Nagai, Yoshimi, Sho, Kenichiro, Tsumura, Akiko, Koike, Naoko, Tsuda, Mei, Nishimura, Tetsuya, Takahashi, Kanji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726592/ https://www.ncbi.nlm.nih.gov/pubmed/23901256 http://dx.doi.org/10.2147/OPTH.S46317 |
Ejemplares similares
-
Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
por: Koike, Naoko, et al.
Publicado: (2019) -
Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
por: Otsuji, Tsuyoshi, et al.
Publicado: (2016) -
The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013) -
Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
por: Yanagi, Yasuo, et al.
Publicado: (2023) -
Role of ranibizumab in management of macular degeneration
por: Singh, Rishi P, et al.
Publicado: (2007)